Temporal patterns of head and neck squamous cell carcinoma recurrence with positron‐emission tomography/computed tomography monitoring
- 5 April 2012
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 122 (7) , 1512-1517
Abstract
Objectives/Hypothesis: To estimate the distribution of head and neck squamous cell carcinoma (HNSCC) recurrence after definitive chemoradiation therapy (CRT) among patients who underwent 18F‐fluorodeoxyglucose positron‐emission tomography and computed tomography (PET/CT) surveillance.Study Design: Retrospective review.Methods: HNSCC patients who underwent definitive CRT from 2001 to 2008 were evaluated for recurrence with serial PET/CT. Patients were excluded if they were previously treated for recurrent disease, were treated with surgery as the primary therapeutic modality, or had inadequate clinical follow‐up. Recurrence was defined by histopathologic evidence of tumor.Results: Three hundred eighty‐eight patients were studied. Patients in whom recurrence was not detected were followed clinically and radiographically for a median of 27 months. Tumor recurrence was detected in 110 patients. For 37 patients, recurrence was heralded by clinical signs. Among the 73 asymptomatic patients who had a confirmed recurrence, disease was detected by PET/CT between 2 and 43 months, median of 6 months. Forty‐five percent of observed asymptomatic recurrences were detected during the first 6 months of surveillance (95% confidence interval [CI], 34%‐57%), 79% within the first 12 months (95% CI, 68%‐88%), 95% within the first 24 months (95% CI, 87%‐98%), and 100% within the first 48 months (95% CI, 95%‐100%).Conclusions: Among HNSCC patients followed with PET/CT surveillance, 95% of observed asymptomatic recurrences were detected within 24 months after completing CRT. For patients without clinical signs of recurrence, routine PET/CT surveillance beyond the first 24 months may be of limited value and may not be cost effective. Laryngoscope, 2012Keywords
This publication has 18 references indexed in Scilit:
- Oral squamous cell carcinoma and a clinically negative neck: The value of follow‐upHead & Neck, 2010
- Cancer Risks After Radiation Exposure in Middle AgeJNCI: Journal of the National Cancer Institute, 2010
- Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapyAnnals of Oncology, 2010
- The diagnostic and prognostic utility of positron emission tomography/computed tomography‐based follow‐up after radiotherapy for head and neck cancerCancer, 2009
- Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?Journal of Nuclear Medicine, 2008
- Recent Advances in Head and Neck CancerNew England Journal of Medicine, 2008
- Deferring Planned Neck Dissection Following Chemoradiation for Stage IV Head and Neck Cancer: The Utility of PET‐CTThe Laryngoscope, 2007
- Value of routine follow‐up for patients cured of laryngeal carcinomaCancer, 2004
- Postradiotherapy surveillance practice for head and neck squamous cell carcinoma—too much for too little?Head & Neck, 2003
- The value of follow-up in patients treated for squamous cell carcinoma of the head and neckEuropean Journal of Cancer, 1992